Citation Impact
Citing Papers
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
2013 Standout
Colonic bacterial composition in Parkinson's disease
2015 Standout
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
Regulation of hypoxia‐inducible factor‐α isoforms and redox state by carotid body neural activity in rats
2014 StandoutNobel
Cognitive decline in Parkinson disease
2017
Ferroptosis: molecular mechanisms and health implications
2020 Standout
Regulation of carotid body oxygen sensing by hypoxia-inducible factors
2015 StandoutNobel
The Epidemiology of Obesity: A Big Picture
2014 Standout
Cell-based therapies for Parkinson disease—past insights and future potential
2015
Parkinson disease
2017 Standout
International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
2018
Parkinson's disease
2021 Standout
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities
2013
Cutaneous neuropathy in Parkinson’s disease: a window into brain pathology
2014
Neuroimaging in Parkinson disease: from research setting to clinical practice
2014
High frequency of mitochondrial complex I mutations in Parkinson’s disease and aging
2004
Microglial cell origin and phenotypes in health and disease
2011 Standout
Optogenetics: 10 years of microbial opsins in neuroscience
2015 Standout
Ageing as a risk factor for neurodegenerative disease
2019 Standout
miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions
2013
Cadmium inhibits the electron transfer chain and induces Reactive Oxygen Species
2004
Psychedelics
2016 Standout
Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis
2015
Global mapping of miRNA-target interactions in cattle (Bos taurus)
2017 StandoutNobel
Parkinson's disease
2009 Standout
Mitochondrial DNA, base excision repair and neurodegeneration
2008
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
Is there a future for therapeutic use of transcranial magnetic stimulation?
2007
A practical guide to diagnostic transcranial magnetic stimulation: Report of an IFCN committee
2012 Standout
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
2013 Standout
Short latency cerebellar modulation of the basal ganglia
2014
Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research
2009 Standout
DNA Damage, Aging, and Cancer
2009 Standout
A clinico-pathological study of subtypes in Parkinson's disease
2009
Higher iron in the red nucleus marks Parkinson's dyskinesia
2012
miRNA–target chimeras reveal miRNA 3′-end pairing as a major determinant of Argonaute target specificity
2015 StandoutNobel
Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease
2012
Sensory aspects of movement disorders
2013
Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Structural Imaging in Parkinson’s Disease: New Developments
2019
Parkinson's disease
2015 Standout
The clinical diagnostic utility of transcranial magnetic stimulation: Report of an IFCN committee
2007
BTS guidelines for the management of community acquired pneumonia in adults: update 2009
2009
Mitochondrial DNA mutations in neurodegeneration
2015
The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease
2011
Idiopathic pulmonary fibrosis
2017 Standout
Interplay Between Lipid Metabolism and Autophagy
2020
Obesity and the risk and outcome of infection
2012
Apolipoprotein E in Alzheimer's disease and other neurological disorders
2011
Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease: A Systematic Review and Meta-Analysis
2018
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Gaseous messengers in oxygen sensing
2012 StandoutNobel
Levodopa–Carbidopa Intestinal Gel in Patients with Parkinson’s Disease: A Systematic Review
2016
Non-motor features of Parkinson disease
2017 Standout
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
Visual symptoms in Parkinson's disease and Parkinson's disease dementia
2011
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
2019 StandoutNature
Imaging biomarkers in Parkinson's disease
2011
Peripheral Chemoreceptors: Function and Plasticity of the Carotid Body
2012
The Pathobiology of Vascular Dementia
2013 Standout
Cluster headache: pathogenesis, diagnosis, and management
2005
Glucocerebrosidase deficiency promotes protein aggregation through dysregulation of extracellular vesicles
2018
GBA1-associated parkinsonism: new insights and therapeutic opportunities
2019
Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations
2013
Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation
2006
Hyposmia and cognitive impairment in Gaucher disease patients and carriers
2012
Preclinical Biomarkers of Parkinson Disease
2011
The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa
2014
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes
2013
Brain iron metabolism: Neurobiology and neurochemistry
2007
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Criteria for the diagnosis of corticobasal degeneration
2013 Standout
Prospective study of plasma urate and risk of Parkinson disease in men and women
2016
Polyneuropathies.
2018
Alzheimer's disease
2017 Standout
Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling
2011 Standout
Exosomes
2019 Standout
The neuropathological diagnosis of Alzheimer’s disease
2019 Standout
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Plasma urate and risk of Parkinson's disease: A mendelian randomization study
2018
MDS clinical diagnostic criteria for Parkinson's disease
2015 Standout
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Long‐term safety and efficacy of levodopa‐carbidopa intestinal gel in advanced Parkinson's disease
2018
Gut microbiota are related to Parkinson's disease and clinical phenotype
2014 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective
2016
Longitudinal follow-up of SWEDD subjects in the PRECEPT Study
2014
The Effects of Cadmium Toxicity
2020 Standout
Cognitive and motor assessment in autopsy-proven corticobasal degeneration
2007
Complementary roles of gasotransmitters CO and H2S in sleep apnea
2017 StandoutNobel
The role of hypoxia‐inducible factors in carotid body (patho) physiology
2018 StandoutNobel
Apomorphine in the treatment of Parkinson's disease: a review
2018
Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson’s Disease-Linked LRRK2 Mutant G2019S
2013
Mendelian randomization of serum urate and parkinson disease progression
2014
Oxygen Sensing and Homeostasis
2015 StandoutNobel
Protein kinase G–regulated production of H 2 S governs oxygen sensing
2015 StandoutNobel
MRI Findings in Neuroferritinopathy
2011
Nonmotor fluctuations in Parkinson disease
2013
H 2 S production by reactive oxygen species in the carotid body triggers hypertension in a rodent model of sleep apnea
2016 StandoutNobel
Works of Pablo Mir being referenced
Consensus on the Definition of Advanced Parkinson’s Disease: A Neurologists-Based Delphi Study (CEPA Study)
2017
In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson’s disease
2017
Low serum uric acid concentration in Parkinson's disease in southern Spain
2012
COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression
2016
Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients
2009
GBA Variants Influence Motor and Non-Motor Features of Parkinson’s Disease
2016
Prevalence and clinical features of LRRK2 mutations in patients with Parkinson’s disease in southern Spain
2009
Polyneuropathy while on duodenal levodopa infusion in Parkinson’s disease patients: we must be alert
2012
Clinical features and123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease
2012
Long-term levodopa/carbidopa intestinal gel in advanced Parkinson’s disease
2014
New evidence of risk factors for community-acquired pneumonia: a population-based study
2008
Patients with adult‐onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs)
2007
Secondary generalized dystonia without basal ganglia damage
2005
Genetic association of sirtuin genes and Parkinson’s disease
2013
Mitochondrial DNA A4336G Mutation in Alzheimer’s and Parkinson’s Diseases
2002
Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: A clinical and electrophysiological study
2010
Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson’s disease experiencing mild wearing-off: a randomised, double-blind trial
2013
Dopaminergic drugs restore facilitatory premotor-motor interactions in Parkinson disease
2005
Brain-derived neurotrophic factor G196A polymorphism and clinical features in Parkinson’s disease
2010
Prophylactic treatment of episodic cluster headache with intravenous bolus of methylprednisolone
2003
Carotid body autotransplantation in Parkinson disease: a clinical and positron emission tomography study
2007
Secondary and primary dystonia: pathophysiological differences
2013
Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs)
2009
Adult‐onset generalized dystonia due to a mutation in the neuroferritinopathy gene
2004
N370S‐GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson's disease
2017
Motor system inhibition in dopa-responsive dystonia and its modulation by treatment
2006
Genetic variability related to serum uric acid concentration and risk of Parkinson's disease
2013
Advanced Parkinson's disease: Clinical characteristics and treatment (part 1)
2013
Long-term Effectiveness of levodopa–carbidopa Intestinal Gel in 177 Spanish Patients With Advanced Parkinson’s Disease
2016
Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease
2009
International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease
2009
[Apolipoprotein E4 in dementia with Lewy bodies].
2008